Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Youngmi Jung
Cells (2019) Vol. 8, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress
Xiang Du, Yang Liu, Shujun Zhou, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 117
Pharmacological treatment options for metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review
L Konings, Lorena Miguelañez‐Matute, Anna M P Boeren, et al.
European Journal of Clinical Investigation (2025)
Open Access | Times Cited: 1
Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Feng‐Bin Lu, Kenneth I. Zheng, Rafael S. Rios, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 12, pp. 2041-2050
Open Access | Times Cited: 93
Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement
Aditi Bhargava, Arthur P. Arnold, Debra A. Bangasser, et al.
Endocrine Reviews (2021) Vol. 42, Iss. 3, pp. 219-258
Open Access | Times Cited: 90
Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease
Philippe Lefèbvre, Bart Staels
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 11, pp. 662-670
Closed Access | Times Cited: 70
Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Jinsol Han, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Menopause and metabolic dysfunction-associated steatotic liver disease
Stergios A. Pοlyzos, Dimitrios G. Goulis
Maturitas (2024) Vol. 186, pp. 108024-108024
Closed Access | Times Cited: 7
Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017–2020
Na Zhu, Yanyan Li, Yingying Lin, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Alfredo Smiriglia, Nicla Lorito, Marina Bacci, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies
Changhua Zhang, Bu-Gao Zhou, Junqing Sheng, et al.
Pharmacological Research (2020) Vol. 159, pp. 104984-104984
Closed Access | Times Cited: 39
Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease
Jun‐Hyuk Lee, Hye Sun Lee, Sang Bong Ahn, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 10, pp. 5252-5260
Closed Access | Times Cited: 39
Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver–Adipose Tissue Crosstalk
Andrea Morán-Costoya, Ana M. Proenza, Magdalena Gianotti, et al.
Antioxidants and Redox Signaling (2021) Vol. 35, Iss. 9, pp. 753-774
Closed Access | Times Cited: 34
Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease
Stergios A. Pοlyzos, Ιrene Lambrinoudaki, Dimitrios G. Goulis
HORMONES (2022) Vol. 21, Iss. 3, pp. 375-381
Closed Access | Times Cited: 23
Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study
Sergio Fresneda, Manuela Abbate, Carla Busquets-Cortés, et al.
Biology of Sex Differences (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration
Sung Eun Kim, Ji-Song Min, Saemi Lee, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNA Thr production
Xihui Xu, Rozhin Penjweini, Lóránt Székvölgyi, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 1
Open Access
Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats
Yong Hee Lee, Ji Yeon Son, Kyeong Seok Kim, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3709-3709
Open Access | Times Cited: 36
Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation
Serena Farruggio, Grazia Cocomazzi, Patrizia Marotta, et al.
Cellular Physiology and Biochemistry (2020) Vol. 54, Iss. 3, pp. 401-416
Open Access | Times Cited: 32
A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation
Mohammad Yasin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine Khachatryan, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 12, pp. 7485-7503
Open Access | Times Cited: 10
Phthalate Biomarkers Composition in Relation to Fatty Liver: Evidence from Epidemiologic and in vivo studies
Shucong Chen, Hang Liu, Yulian Sun, et al.
The Science of The Total Environment (2024) Vol. 924, pp. 171607-171607
Closed Access | Times Cited: 3
Hypogonadism and nonalcoholic fatty liver disease
Kasiani Papadimitriou, Athanasios Mousiolis, Gesthimani Mintziori, et al.
Endocrine (2024) Vol. 86, Iss. 1, pp. 28-47
Closed Access | Times Cited: 3
Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease
Milton Boaheng Antwi, Ariann Jennings, Sander Lefere, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea
Goh Eun Chung, Eun Ju Cho, Ji Won Yoon, et al.
Metabolism (2021) Vol. 123, pp. 154866-154866
Closed Access | Times Cited: 24
Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
Hongmei Yan, Weiyun Wu, Xinxia Chang, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 23
The Ameliorating Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are SIRT1-Dependent: Evidence from Hepatic-Specific SIRT1 Heterozygous Mutant C57BL/6 Mice
Yan Yin, Deming Li, Fang Liu, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 18, pp. 5579-5594
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top